Vertex Pharmaceuticals
VRTX
#180
Rank
$114.00 B
Marketcap
$444.64
Share price
1.75%
Change (1 day)
-5.24%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Cash on Hand

Cash on Hand as of September 2025 : $6.28 Billion USD

According to Vertex Pharmaceuticals's latest financial reports the company has $6.28 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vertex Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$6.11 B-45.48%
2023-12-31$11.21 B4.08%
2022-12-31$10.77 B43.24%
2021-12-31$7.52 B13.01%
2020-12-31$6.65 B74.85%
2019-12-31$3.80 B20.2%
2018-12-31$3.16 B51.69%
2017-12-31$2.08 B45.6%
2016-12-31$1.43 B37.61%
2015-12-31$1.04 B-24.85%
2014-12-31$1.38 B-5.32%
2013-12-31$1.46 B10.89%
2012-12-31$1.32 B36.36%
2011-12-31$0.96 B-6.06%
2010-12-31$1.03 B-19.73%
2009-12-31$1.28 B54.42%
2008-12-31$0.83 B80.55%
2007-12-31$0.46 B-34.59%
2006-12-31$0.70 B95.1%
2005-12-31$0.36 B-6.5%
2004-12-31$0.38 B-33.77%
2003-12-31$0.58 B-8.16%
2002-12-31$0.63 B-14.56%
2001-12-31$0.74 B61.59%
2000-12-31$0.45 B144.9%
1999-12-31$0.18 B676.04%
1998-12-31$24.2 M-66.15%
1997-12-31$71.5 M104.87%
1996-12-31$34.9 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
$7.34 B 16.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$5.67 B-9.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 189.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 162.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 195.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
$0.20 B-96.75%๐Ÿ‡บ๐Ÿ‡ธ USA